Thursday 28 January 2021
Home      All news      Contact us      RSS     
healtheuropa - 2 month ago

Pritelivir phase III clinical trials for HSV immunocompromised patients

The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infections. Immunocompromised patients with HSV often have a chronic form of the disease which is resistant to any anti-viral medication, including acyclovir. Following Phase I and II trials of Pritelivir, AiCuris, [ ] The post Pritelivir phase III clinical trials for HSV immunocompromised patients appeared first on Health Europa.


Latest News
Hashtags:   

Pritelivir

 | 

phase

 | 

clinical

 | 

trials

 | 

immunocompromised

 | 

patients

 | 

Sources